Elevated tissue transglutaminase immunoglobulin A: Celiac disease or polytypic plasmacytosis?
Abstract We report a case of an adolescent girl post cardiac transplant with hypergammaglobulinemia and presumed celiac disease (CD), who had a persistently elevated anti‐tissue transglutaminase immunoglobulin A despite a gluten free diet. Refractory CD and Crohn's disease were excluded.
Andrew Turunen+4 more
wiley +1 more source
Association between gastrointestinal lesions in individuals undergoing gastroscopy and colonoscopy simultaneously: a retrospective, observational study. [PDF]
Liu Y+13 more
europepmc +1 more source
Influence of cigarette smoking on healing and relapse in duodenal ulcer disease
M. G. Korman+3 more
openalex +1 more source
Post-traumatic stress disorder, attention deficit and hyperactivity disorder, and 24 gastrointestinal diseases: Evidence from Mendelian randomization analysis. [PDF]
Ma L, Li X, Zhang Y.
europepmc +1 more source
Kerckring duodenal folds in celiac disease
Gino Roberto Corazza+3 more
openalex +1 more source
The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years. Aims We aimed to describe the milestones of the gut‐brain axis research in PD and the development of theories proposing the involvement of the ...
Elisa Menozzi+2 more
wiley +1 more source
Eosinophilic gastroenteritis with severe gastrointestinal intolerance: A case report and literature review. [PDF]
Wei CX, Gao YD, Liang R, Lyu T.
europepmc +1 more source
STUDIES ON DUODENAL CYCLIC AMP IN PANCREATIC DISEASE USING THE PANCREOZYMIN-SECRETIN TEST
R Matsumoto
openalex +2 more sources
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss+10 more
wiley +1 more source